Feasibility of Multi-gene Panel Testing at the Time of Diagnosis for Patients With Ovarian Cancer

Completed

Conditions studied: Ovarian Cancer

In brief

The purpose of this study is to determine the feasibility of routine referral to genetic counseling for all patients with a new diagnosis of epithelial ovarian, primary peritoneal or fallopian tube cancer.

Key facts

Study ID

NCT03656809

Run by

NYU Langone Health

People needed

125

Starts

2015-10-15

Expected to finish

2020-01-29

Last updated by the study team

2020-08-10

Who can join

Age: 18 and older, up to 90. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• All subjects must have a new diagnosis of epithelial ovarian, primary peritoneal, fallopian tube or extra- uterine mullerian cancer.
• All subjects must have either undergone primary surgery or be planning neoadjuvant chemotherapy for the treatment of ovarian, primary peritoneal or fallopian tube cancer.
• All subjects must be able to comprehend and communicate in English.
• All subjects must agree to participate.
• A previous diagnosis of cancer is not an exclusion criterion.
• Previous genetic screening is not an exclusion criterion.

You may not qualify if…

• Patients who do not meet the above inclusion criteria.
• Patients with a diagnosis of a low malignant potential mullerian tumor.
• Patients who are not proficient in English language because the survey aspect of this study is comprised of 4 validated surveys that are only available in English language.

Where it is running

• New York University School of Medicine — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.